Usefulness of serial measurement of N-terminal pro-brain natriuretic peptide plasma levels in asymptomatic patients with aortic stenosis to predict symptomatic deterioration
Authors:
- Ivor L. GerberIGIvor L. Gerber
- Malcolm E. LeggetMLMalcolm E. Legget
- Teena M. WestTWTeena M. West
- A. Mark RichardsARA. Mark Richards
- Ralph A.H. StewartRSRalph A.H. Stewart
- 1 April 2005
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 95 (7) , 898-901
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Natriuretic Peptides Predict Symptom-Free Survival and Postoperative Outcome in Severe Aortic StenosisCirculation, 2004
- Increased Plasma Natriuretic Peptide Levels Reflect Symptom Onset in Aortic StenosisCirculation, 2003
- Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrationsThe Lancet, 2000
- Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairmentClinical Endocrinology, 1997
- Prospective Study of Asymptomatic Valvular Aortic StenosisCirculation, 1997
- A practical guide to assessment of ventricular diastolic function using doppler echocardiographyJACC, 1996
- Recommendations for Quantitation of the Left Ventricle by Two-Dimensional EchocardiographyJournal of the American Society of Echocardiography, 1989
- Determination of the stenotic aortic valve area in adults using Doppler echocardiographyJACC, 1986